Date: May 5 – 6, 2026 Day1: Tue, May 05 8:30 a.m. – 05:30 p.m. ET Day2: Wed, May 06 8:30 a.m. – 04:30 p.m. ET Location:

Event Location

The Universities at Shady Grove
Building II

9630 Gudelsky Drive
Rockville, MD 20850
United States

Event Details

The field of generic oral drug products continues to evolve leading to innovative bioequivalence (BE) approaches when conventional in vivo bioequivalence study designs may not be feasible. In response to these evolving complexities, this workshop is designed to address the latest advancements and regulatory challenges in the field, offering a unique platform to engage with all relevant parties, share knowledge, and contribute to the evolution of generic oral product development and regulatory assessment.

Attendees will gain valuable insights into the intricacies of developing generic oral products across diverse areas, including oncology drugs, unavailable reference listed drugs or reference standards, and drug products that are reformulated to mitigate nitrosamine risks. In addition to a series of expert-led presentations and panel discussions, in-person attendees will interact directly with experts from industry, consulting groups, academia and FDA in small group working sessions to deepen their understanding of current practices and challenges, regulatory expectations, and emerging trends. Specifically, the 2-day workshop will cover critical areas such as bioequivalence approaches for oral oncology products, risk assessment and regulatory decision making for nitrosamine-driven reformulation, demonstration of bioequivalence when a reference listed drug or reference standard is unavailable, biopredictive dissolution, and regulatory acceptance of innovative and alternative bioequivalence approaches for generic oral products. These topics reflect the most pressing challenges facing generic oral drug development today and the scientific innovations being deployed to overcome them.

For more information, please visit the Center for Research on Complex Generics website for this Workshop

  • Content current as of:

    04/10/2026

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.